{"title":"一种罕见的肺肿瘤,肝样腺癌","authors":"S. Jasqui-Remba","doi":"10.15406/mojcr.2020.10.00342","DOIUrl":null,"url":null,"abstract":"Hepatoid adenocarcinoma is a rare neoplasm,1 named for its histopathological and immunohistochemical similarity with the hepatocellular carcinoma. The extrahepatic localization has a poor prognosis and tends to occur more frequently in the stomach. An important characteristic is the ability to produce alpha-fetoprotein, like many other pulmonary neoplasms. Its ability to respond to treatment and the possibility of recurrence is another relevant characteristic.2,3","PeriodicalId":93339,"journal":{"name":"MOJ clinical & medical case reports","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A rare tumor of the lung, hepatoid adenocarcinoma\",\"authors\":\"S. Jasqui-Remba\",\"doi\":\"10.15406/mojcr.2020.10.00342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatoid adenocarcinoma is a rare neoplasm,1 named for its histopathological and immunohistochemical similarity with the hepatocellular carcinoma. The extrahepatic localization has a poor prognosis and tends to occur more frequently in the stomach. An important characteristic is the ability to produce alpha-fetoprotein, like many other pulmonary neoplasms. Its ability to respond to treatment and the possibility of recurrence is another relevant characteristic.2,3\",\"PeriodicalId\":93339,\"journal\":{\"name\":\"MOJ clinical & medical case reports\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MOJ clinical & medical case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/mojcr.2020.10.00342\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MOJ clinical & medical case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/mojcr.2020.10.00342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hepatoid adenocarcinoma is a rare neoplasm,1 named for its histopathological and immunohistochemical similarity with the hepatocellular carcinoma. The extrahepatic localization has a poor prognosis and tends to occur more frequently in the stomach. An important characteristic is the ability to produce alpha-fetoprotein, like many other pulmonary neoplasms. Its ability to respond to treatment and the possibility of recurrence is another relevant characteristic.2,3